[Research progress of conversion therapy in colorectal cancer liver metastases].

Zhang, Y Y; Chen, S W; Wang, P Y; Liu, Y C

Zhang, Y Y; Chen, S W; Wang, P Y; Liu, Y C.

Affiliation

Zhang YY; Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
Chen SW; Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
Wang PY; Department of General Surgery, Peking University First Hospital, Beijing 100034, China.
Liu YC; Department of General Surgery, Peking University First Hospital, Beijing 100034, China.

Zhonghua Wei Chang Wai Ke Za Zhi ; 24(1): 85-93, 2021 Jan 25.

Article in Zh | MEDLINE | ID: mdl-33461258

Subject(s)

Colorectal Neoplasms; Combined Modality Therapy/methods; Liver Neoplasms; Biomedical Research; Colorectal Neoplasms/pathology; Colorectal Neoplasms/surgery; Colorectal Neoplasms/therapy; Hepatectomy; Humans; Liver Neoplasms/secondary; Liver Neoplasms/surgery; Liver Neoplasms/therapy; Prognosis

Key words

Colorectal cancer liver metastases; Conversion therapy; Immune checkpoint inhibitors; Locoregional therapy; Targeted therapy

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Colorectal Neoplasms / Combined Modality Therapy / Liver Neoplasms Type of study: Prognostic_studies Limits: Humans Language: Zh Year: 2021 Type: Article

Fulltext

XML

PubMed Links

Search on Google